Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.540
+0.160 (4.73%)
At close: Oct 28, 2026, 4:00 PM EDT
3.444
-0.096 (-2.71%)
After-hours: Oct 28, 2026, 7:30 PM EDT
Galectin Therapeutics Market Cap
Galectin Therapeutics has a market cap or net worth of $357.01 million as of October 28, 2026. It is the 16,864th most valuable company in the world and the 3,018th biggest in the United States. Its market cap has increased by 9.28% in one year.
Market Cap
357.01M
Enterprise Value
487.69M
1-Year Change
9.28%
Global Rank
Country Rank
#3,018 United States
Category
ChartMarket Cap Chart
Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $357.01M, an increase of 234.28%. That is a compound annual growth rate of 5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 357.00M | 33.11% |
| Dec 31, 2025 | 268.20M | 231.11% |
| Dec 31, 2024 | 81.00M | -21.13% |
| Dec 29, 2023 | 102.70M | 52.83% |
| Dec 30, 2022 | 67.20M | -45.28% |
| Dec 31, 2021 | 122.80M | -3.99% |
| Dec 31, 2020 | 127.90M | -21.39% |
| Dec 31, 2019 | 162.70M | 15.31% |
| Dec 31, 2018 | 141.10M | 18.57% |
| Dec 29, 2017 | 119.00M | 313.19% |
| Dec 30, 2016 | 28.80M | -26.53% |
| Dec 31, 2015 | 39.20M | -48.96% |
| Dec 31, 2014 | 76.80M | -48.11% |
| Dec 31, 2013 | 148.00M | 352.60% |
| Dec 31, 2012 | 32.70M | -55.81% |
| Dec 30, 2011 | 74.00M | 32.14% |
| Dec 31, 2010 | 56.00M | 288.89% |
| Dec 31, 2009 | 14.40M | 234.88% |
| Dec 31, 2008 | 4.30M | -84.81% |
| Dec 31, 2007 | 28.30M | 111.19% |
| Dec 29, 2006 | 13.40M | -83.91% |
| Dec 30, 2005 | 83.30M | 21.96% |
| Dec 31, 2004 | 68.30M | -23.94% |
| Dec 31, 2003 | 89.80M | -15.92% |
| Sep 10, 2003 | 106.80M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 381.85M |
| Fennec Pharmaceuticals | 381.18M |
| Kyverna Therapeutics | 364.26M |
| ARS Pharmaceuticals | 362.98M |
| Capricor Therapeutics | 362.21M |
| Orchestra BioMed Holdings | 360.03M |
| Relmada Therapeutics | 357.34M |
| Contineum Therapeutics | 344.23M |